Insights

Innovative AI Solutions Cyntegrity’s advanced AI-augmented risk management and predictive analytics solutions cater directly to the needs of clinical research organizations, sponsors, and regulators seeking to streamline and enhance trial quality and compliance. Highlighting their recent integrations and forward-looking AI capabilities presents opportunities to pitch customized SaaS and PaaS offerings for institutions aiming to adopt next-generation clinical trial technologies.

Expanding Digital Ecosystem The launch of the MyRBQM Portal in the Microsoft Azure Marketplace and the development of online platforms like MyRBQM Academy and mindON RBQM series demonstrate a strategic focus on digital transformation and knowledge sharing. These initiatives suggest a growing demand among industry professionals for cloud-based RBQM solutions and educational services, offering sales avenues for related platform licensing, training programs, and service subscriptions.

Market Growth Potential With a revenue range of $250M to $500M and a specialized focus within the global bioPharma industry, Cyntegrity operates in a high-growth market segment aligned with increasing regulation and need for risk-based quality management. Their positioning as a provider compliant with ICH GCP E6(R3) and other standards creates opportunities to target pharmaceutical companies, CROs, and regulatory bodies investing in scalable, AI-driven CQMS solutions.

Global Talent Pool Cyntegrity’s diverse international team and presence across 14 countries illustrate the company’s capacity to serve global clients and adapt culturally nuanced solutions. This geographic and cultural breadth enables sales efforts directed toward multinational biopharma firms needing localized yet standardized RBQM and clinical trial services, opening pathways for tailored enterprise solutions.

Complementary Data Tools The recent launch of tools like the openFDA Drug Interaction Visualizer and COVID-19 mitigation resources indicates a capacity for developing niche data visualization and risk assessment products. These assets can be leveraged to upsell integrated data analytics packages, risk visualization tools, and compliance solutions to pharma companies seeking to enhance their pharmacovigilance and clinical trial oversight capabilities.

Cyntegrity | We De-risk Clinical Trials Tech Stack

Cyntegrity | We De-risk Clinical Trials uses 8 technology products and services including RSS, Vue.js, Modernizr, and more. Explore Cyntegrity | We De-risk Clinical Trials's tech stack below.

  • RSS
    Content Management System
  • Vue.js
    Javascript Frameworks
  • Modernizr
    Javascript Libraries
  • HSTS
    Security
  • ZURB Foundation
    UI Frameworks
  • IONOS
    Web Hosting
  • The Events Calendar
    Web Platform Extensions
  • FitVids.js
    Web Tools And Plugins

Media & News

Cyntegrity | We De-risk Clinical Trials's Email Address Formats

Cyntegrity | We De-risk Clinical Trials uses at least 1 format(s):
Cyntegrity | We De-risk Clinical Trials Email FormatsExamplePercentage
First.Last@cyntegrity.comJohn.Doe@cyntegrity.com
47%
First.Middle@cyntegrity.comJohn.Michael@cyntegrity.com
3%
First.Last@cyntegrity.comJohn.Doe@cyntegrity.com
47%
First.Middle@cyntegrity.comJohn.Michael@cyntegrity.com
3%

Frequently Asked Questions

What is Cyntegrity | We De-risk Clinical Trials's official website and social media links?

Minus sign iconPlus sign icon
Cyntegrity | We De-risk Clinical Trials's official website is cyntegrity.com and has social profiles on LinkedInCrunchbase.

What is Cyntegrity | We De-risk Clinical Trials's NAICS code?

Minus sign iconPlus sign icon
Cyntegrity | We De-risk Clinical Trials's NAICS code is 5415 - Computer Systems Design and Related Services.

How many employees does Cyntegrity | We De-risk Clinical Trials have currently?

Minus sign iconPlus sign icon
As of December 2025, Cyntegrity | We De-risk Clinical Trials has approximately 51 employees across 4 continents, including EuropeAfricaAsia. Key team members include Ceo & Founder: A. A.Chief Scientific Officer: J. P.Head Of Customer Success: N. A. B.. Explore Cyntegrity | We De-risk Clinical Trials's employee directory with LeadIQ.

What industry does Cyntegrity | We De-risk Clinical Trials belong to?

Minus sign iconPlus sign icon
Cyntegrity | We De-risk Clinical Trials operates in the IT Services and IT Consulting industry.

What technology does Cyntegrity | We De-risk Clinical Trials use?

Minus sign iconPlus sign icon
Cyntegrity | We De-risk Clinical Trials's tech stack includes RSSVue.jsModernizrHSTSZURB FoundationIONOSThe Events CalendarFitVids.js.

What is Cyntegrity | We De-risk Clinical Trials's email format?

Minus sign iconPlus sign icon
Cyntegrity | We De-risk Clinical Trials's email format typically follows the pattern of First.Last@cyntegrity.com. Find more Cyntegrity | We De-risk Clinical Trials email formats with LeadIQ.

When was Cyntegrity | We De-risk Clinical Trials founded?

Minus sign iconPlus sign icon
Cyntegrity | We De-risk Clinical Trials was founded in 2013.

Cyntegrity | We De-risk Clinical Trials

IT Services and IT ConsultingHesse, Germany51-200 Employees

Cyntegrity is a premier provider of AI-augmented, risk-based quality management solutions in the BioPharma industry. Our AI journey began in 2017 with the introduction of Machine Learning predictive analytics, enhancing the accuracy and efficiency of our services. By 2020, we expanded our AI capabilities to include predictive analytics for all clinical research metrics, further refining our solutions.

In 2023, we introduced "Ask AI" for clinical risk assessment and AI-augmented regulatory inspections, streamlining our clients' operations. As we celebrate our 10th anniversary in 2024, we're proud to add AI-augmented clinical Due Diligence to our services, providing even more comprehensive solutions.

Our proprietary MyRBQM® Portal, MyRBQM® Academy, and MyRBQM® FSP brands facilitate integrated risk management. We assist sponsors, CROs, regulators, and auditors with AI-augmented data science technology, educational programs, and related functional services, allowing them to focus resources where most needed.

Cyntegrity is powered by an international team of industry specialists from 17 nationalities living in 14 countries. We aim to be the preferred provider of AI-augmented SaaS and PaaS solutions for ICH GCP E6(R3), E8(R1), and Q9(R1) compliant clinical trial risk management, change management, and risk-based regulatory oversight.

Section iconCompany Overview

NAICS Code
5415 - Computer Systems Design and Related Services
Founded
2013
Employees
51-200

Section iconFunding & Financials

  • $250M$500M

    Cyntegrity | We De-risk Clinical Trials's revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $250M$500M

    Cyntegrity | We De-risk Clinical Trials's revenue is estimated to be in the range of $250M$500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.